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Background: Patients with angina pectoris or myocardial infarction frequently present without 
evidence of cardiac-specific heart enzymes by laboratory analysis or specific pathologic electro-
cardiogram findings. The current study analyzed the efficacy of the erythrocyte sedimentation 
rate as an additional potential indicator for coronary heart disease, the aim being to enable 
quicker identification of patients with angina pectoris or myocardial infarction so that they can 
be more rapidly treated.
Methods: Patients with angina pectoris or myocardial infarction who had undergone a heart 
catheter examination were included in the study. The diagnosis of acute coronary heart disease 
was made by the physician who performed coronary angiography. Patients without coronary 
heart disease were used as a control group. The erythrocyte sedimentation rate was measured 
in all patients. Patients with angina pectoris or myocardial infarction and an inflammatory or 
tumor disease were excluded.
Results: The erythrocyte sedimentation rate was prolonged in 79 (58.09%) of 136 patients; 
69 (50.74%) patients (95% confidence interval ±8.4%, 42.34%–59.14%) had coronary heart 
disease and a prolonged erythrocyte sedimentation rate. The erythrocyte sedimentation rate was 
prolonged in ten (7.35%) patients (95% confidence interval ±4.39%, 2.96%–11.74%) without 
coronary heart disease by coronary angiography. The specificity of the erythrocyte sedimentation 
rate for coronary heart disease was 70.59% and the sensitivity was 67.65%.
Conclusion: Erythrocyte sedimentation rate may be a useful additional diagnostic criterion 
for coronary heart disease.
Keywords: erythrocyte sedimentation rate, coronary heart disease, myocardial infarction, 
coronary angiography
Introduction
Determination of the erythrocyte sedimentation rate is a nonspecific test that   constitutes 
one of the oldest laboratory methods. An accelerated erythrocyte sedimentation rate 
may be indicative of inflammation or the presence of a tumor. However, a slow 
  erythrocyte sedimentation rate may occur (eg, in polycythemia vera). Despite the 
  critical role of cytokines in inflammatory conditions, the erythrocyte sedimentation rate 
still plays an important role in the diagnosis and follow-up of rheumatoid arthritis and 
temporal arthritis, sickle cell disease, and osteomyelitis, as well as in noninflammatory 
conditions such as stroke, coronary artery disease, and prostate cancer.1
Patients with symptoms of angina pectoris or myocardial infarction frequently 
present without striking evidence of cardiac-specific enzymes in blood laboratory 
assessments or specific electrocardiogram findings. The purpose of this study was 
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to assess the efficacy of the erythrocyte sedimentation rate 
as a potential additional indicator for coronary heart disease 
so that patients with angina pectoris or myocardial infarction 
can be more rapidly identified and treated.
This study differs from other studies in that all patients 
were examined by coronary angiography with multiple blood 
tests and patients with inflammation and tumor were excluded 
from this study. This meant that the erythrocyte sedimentation 
rate and acute coronary heart disease could be studied better 
by close temporal investigations.
Materials and methods
This was a retrospective study of patients with angina 
pectoris, non-ST-elevation myocardial infarction, or acute 
myocardial infarction with ST-segment elevation, as assessed 
by electrocardiography. All patients included in this study 
underwent coronary angiography, resulting in the diagnosis 
of acute coronary heart disease. Patients in whom coronary 
heart disease was excluded by coronary angiography served 
as controls. The erythrocyte sedimentation rate was measured 
over a period of 1 hour and 2 hours; normal values were 
considered to be ,10 mm in the first hour and ,20 mm in 
the second hour. The number of leukocytes was also deter-
mined in all patients; the normal number of leukocytes was 
considered to be 4.000–10.000 cells/µL. C-reactive protein 
(CRP) level was determined in all patients, with a normal 
reference value of ,6.0 mg/L. The average number with 
standard deviation of neutrophils, lymphocytes, monocytes, 
eosinophils, and basophils was determined as a percentage 
of patients with prolonged erythrocyte sedimentation rate 
and coronary heart disease. Any inflammatory disease was 
excluded in all patients by clinical and radiologic assessment 
and by urine sediment or urine culture. Patients with angina 
pectoris diagnosed with inflammatory or tumor diseases were 
excluded from the study.
statistical analysis
Data are presented as mean ± standard deviation. The χ2 test 
was used to compare prolonged erythrocyte   sedimentation 
rates between patients with and without coronary heart 
disease. The specificity and sensitivity of the erythrocyte 
sedimentation rate as a marker for coronary artery disease 
and the 95% confidence interval (CI) were calculated.
Results
A total of 136 patients with angina pectoris or acute 
  myocardial infarction were included in this study (Figure 1). 
The cohort included 89 men and 47 women with an average 
age of 69.31 ± 12.45 years.
During cardiac catheterization, 102 (75%) patients were 
found to have coronary heart disease, including 70 (68.63%) 
males and 32 (31.37%) females. A total of 52 (38.24%) 
patients were diagnosed with angina pectoris, 39 (28.67%) 
with non-ST-elevation myocardial infarction, and ten (7.35%) 
with acute ST-elevation myocardial infarction. The indication 
for coronary angiography was performed in 35 (25.74%) 
patients due to changes in the electrocardiogram such as 
negative T, R-regression, and pathological ergometry. Fur-
ther, 59 patients had three-vessel disease, 24 patients had 
two-vessel disease, and 19 patients had one-vessel disease. 
No coronary heart disease was seen in 34 (25%) patients, 
including 19 (55.88%) men and 15 (44.12%) women.
The erythrocyte sedimentation rate was prolonged 
in 79 (58.09%) patients. Coronary heart disease and a 
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Figure 1 The number of cases in this study.
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Figure 2 The value and number prolonged erythrocyte sedimentation rate in patients with an acute coronary heart disease.
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Figure 3 Leukocytosis in patients with acute coronary heart disease and prolonged erythrocyte sedimentation rate
  prolonged erythrocyte sedimentation rate were observed 
in 69 (50.74%) patients (95% CI ±8.4%, 42.34%–59.14%) 
with an average value of 19.68 ± 12.71 mm in the first 
hour and 41.88 ± 19.30 mm in the second hour (Figure 2). 
The erythrocyte sedimentation rate was prolonged in ten 
(7.35%) patients (95% CI ±4.39%, 2.96%–11.74%) without 
signs of significant stenosis by coronary angiography. A normal 
erythrocyte sedimentation rate was seen in 24 (17.65%) 
patients (95% CI ±6.41%, 11.24%–24.06%) without evidence 
of coronary heart disease by cardiac catheterization. In con-
trast, 33 (24.26%) patients (95% CI ± 7.2%, 17.06%–31.46%) 
with a normal erythrocyte sedimentation rate exhibited 
signs of ischemic coronary heart disease by left heart 
catheterization.
The specificity of the erythrocyte sedimentation rate for 
coronary heart disease was 70.59% and the sensitivity was 
67.65%. However, the two-sided significance using the χ2 test 
was not significant for a prolonged erythrocyte sedimentation 
rate being indicative of coronary heart disease.
The average number of leukocytes in all patients was   
8.596  cells/µL ± 2.578 cells/µL. The average increased leukocyte 
value in 35 (25.74%) patients was 12.003 ± 2.108 cells/µL 
and in 19 (13.97%) patients with coronary heart disease and 
prolonged erythrocyte sedimentation rate 12.072 ± 2.183 
cells/µL (Figure 3).
The average elevated CRP value in 49 (36.03%) patients 
was 19.04 ± 20.77 mg/L; in 32 (23.53%) patients with an 
acute coronary heart disease and prolonged erythrocyte 
sedimentation rate 18.67 ± 16.95 mg/L (Figure 4).
The average number of neutrophils was 67.14% ± 11.07% 
(reference range 50%–70%), 22.04% ± 9.70% (20%–52%) 
lymphocytes, 8.75%±2.57% (3%–7%) monocytes, 
submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
221
Erythrocyte sedimentation and heart diseaseVascular Health and Risk Management 2012:8
1.84% ± 1.28% (1%–4%) eosinophils, and 0.37% ± 0.22% 
(0%–1%) basophils. The neutrophils were increased in 27 
(39.13%) patients from a total of 69 patients with coronary 
heart disease and  prolonged erythrocyte sedimentation rate 
with   coronary heart disease.
Discussion
The findings of this study suggest a possible correlation 
between a prolonged erythrocyte sedimentation rate and 
coronary heart disease. Indeed, the erythrocyte sedimentation 
rate was mostly prolonged in patients with coronary heart 
disease. However, although the specificity and sensitivity 
of the erythrocyte sedimentation rate as a marker for coro-
nary heart disease were relatively high, the χ2 test showed a 
nonsignificant effect.
Erikksen et al2 previously reported that the erythrocyte 
sedimentation rate may be a good indicator for coronary 
heart disease, mortality, and the risk of death from coronary 
heart disease. The relationship between the erythrocyte 
sedimentation rate and the risk of coronary heart disease 
was also assessed in a cohort study by Andresdottir et al3 
The authors concluded that the erythrocyte sedimentation 
rate can be used as an independent prognostic factor for 
coronary heart disease in men and women on the basis 
of an inflammatory process of atherosclerosis.3 However, 
it has been shown that the erythrocyte sedimentation rate 
cannot be used for screening and check-up examinations in 
asymptomatic patients.4   Nevertheless, Gillum et al5 described 
that an increased erythrocyte sedimentation rate is a risk 
factor for coronary heart disease. This relationship between 
the erythrocyte sedimentation rate and the risk of coronary 
heart disease was also observed in this study. The other 
inflammatory parameters were also elevated in this study. 
Therefore, this assumption of inflammation as a basis for the 
development of atherosclerosis was also confirmed through 
this recent study.
A relationship between coronary atherosclerosis and 
erythrocyte sedimentation rate was found in a clinical observa-
tion study by Natali et al.6 In the present study, seven patients 
were diagnosed with coronary atherosclerosis by cardiac 
catheterization. In three cases of arteriosclerosis, the 
erythrocyte sedimentation rate was extended in this study.
Serum levels of myocardial enzymes and inflammatory 
biomarkers have been shown not only to be increased in the 
setting of an acute coronary event but also to quantitatively 
correlate with the extent of myocardial damage and coronary 
artery disease severity, according to angiographic findings.7,8 
CRP is the most widely studied inflammatory marker, and 
there is now robust evidence that CRP is a strong predictor 
of cardiovascular risk among apparently healthy individuals, 
patients undergoing elective revascularization procedures, 
and patients presenting with acute coronary syndromes.8–13 
Circulating levels of CRP rise during the acute-phase 
response to tissue injury, infection, and inflammation,8–13 
and CRP, the prototypic acute-phase protein, and to a lesser 
extent fibrinogen, have been proven to be reliable and impor-
tant markers of the risk of ischemic heart disease.7 Also in 
this study, elevated levels of CRP were observed in about 
one third of patients with acute coronary heart disease after 
exclusion of inflammation.
A correlation has also been observed between leukocyte 
count and acute coronary syndrome; investigations of the 
utility of the leukocyte count as a risk factor and   prognostic 
indicator in patients with acute coronary syndrome are con-
sistent with the current concept that atherosclerosis is an 
inflammatory disease.14–17 Leukocytosis induces or worsens 
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Figure 4 CRP in patients with prolonged erythrocyte sedimentation rate and coronary heart disease.
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coronary heart disease through multiple pathologic mecha-
nisms that mediate inflammation, cause proteolytic and oxi-
dative damage to endothelial cells, plug the microvasculature, 
induce hypercoagulability, and promote infarct expansion.16 
In summary, it has been consistently shown that leukocyto-
sis is an independent risk factor and prognostic indicator of 
future cardiovascular outcomes, regardless of disease status.16 
The leukocyte count is inexpensive to obtain, reliable, easy 
to interpret, and ordered routinely in inpatient and outpatient 
settings.16 Also in this study, leukocyte counts in all patients 
with acute coronary heart disease were increased, on aver-
age. Therefore, a relationship between leukocyte account 
and acute coronary heart disease has also been observed in 
this study.
The independent association of neutrophil count with 
the angiographic characteristics of coronary atherosclerosis 
strongly suggests that granulocytosis may play a role in the 
development of coronary atherosclerosis.17 The granulocytes 
from patients with prolonged erythrocyte sedimentation rate 
with coronary heart disease in this study were not increased, 
on average, apart from individual elevated values.
Conclusion
The erythrocyte sedimentation rate was found to be   frequently 
prolonged in patients with coronary heart disease. An increase 
in erythrocyte sedimentation rate provides information about 
the inflammatory etiology of coronary heart disease. The 
erythrocyte sedimentation rate may thus be helpful as an 
additional diagnostic tool for coronary heart disease.
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